celastrol has been researched along with binimetinib in 1 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (binimetinib) | Trials (binimetinib) | Recent Studies (post-2010) (binimetinib) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 166 | 32 | 164 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| A Kim, S; Jeong, Y; Kim, S; Kim, SW; Lee, JE; Nam, SJ; Yoon, SY; You, D | 1 |
1 other study(ies) available for celastrol and binimetinib
| Article | Year |
|---|---|
Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cells.
Topics: Benzimidazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1beta; MAP Kinase Signaling System; Neoplasm Invasiveness; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms | 2021 |